Literature DB >> 19684440

Molecular mechanisms of human papillomavirus-induced carcinogenesis.

Michaël Lehoux1, Claudia M D'Abramo, Jacques Archambault.   

Abstract

Approximately 20% of all cancers are associated with infectious agents. Among them, human papillomaviruses (HPVs) are very common and are now recognized as the etiological agent of cervical cancer, the second most common cancer in women worldwide, and they are increasingly linked with other forms of dysplasia. Carcinogenesis is a complex and multistep process requiring the acquisition of several genetic and/or epigenetic alterations. HPV-induced neoplasia, however, is in part mediated by the intrinsic functions of the viral proteins. In order to replicate its genome, HPV modulates the cell cycle, while deploying mechanisms to escape the host immune response, cellular senescence and apoptosis. As such, HPV infection leads directly and indirectly to genomic instability, further favouring transforming genetic events and progression to malignancy. This review aims to summarize our current understanding of the molecular mechanisms exploited by HPV to induce neoplasia, with an emphasis on the role of the 2 viral oncoproteins E6 and E7. Greater understanding of the role of HPV proteins in these processes will ultimately aid in the development of antiviral therapies, as well as unravel general mechanisms of oncogenesis. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19684440      PMCID: PMC4654617          DOI: 10.1159/000214918

Source DB:  PubMed          Journal:  Public Health Genomics        ISSN: 1662-4246            Impact factor:   2.000


  172 in total

Review 1.  The fabric of cancer cell biology-Weaving together the strands.

Authors:  Richard D Klausner
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

Review 2.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

3.  High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation.

Authors:  X Li; P Coffino
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.

Authors:  D Patel; S M Huang; L A Baglia; D J McCance
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

5.  Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis.

Authors:  D L Jones; D A Thompson; K Münger
Journal:  Virology       Date:  1997-12-08       Impact factor: 3.616

6.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

7.  Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes.

Authors:  Mark R Pett; William O F Alazawi; Ian Roberts; Sally Dowen; David I Smith; Margaret A Stanley; Nicholas Coleman
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

8.  Inhibition of Bak-induced apoptosis by HPV-18 E6.

Authors:  M Thomas; L Banks
Journal:  Oncogene       Date:  1998-12-10       Impact factor: 9.867

Review 9.  HPV: from infection to cancer.

Authors:  M A Stanley; M R Pett; N Coleman
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

10.  Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex.

Authors:  Lindy Gewin; Hadley Myers; Tohru Kiyono; Denise A Galloway
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

View more
  44 in total

1.  Inhibition of human papillomavirus DNA replication by an E1-derived p80/UAF1-binding peptide.

Authors:  Michaël Lehoux; Amélie Fradet-Turcotte; Mathieu Lussier-Price; James G Omichinski; Jacques Archambault
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Characterization of human papillomavirus type 120: a novel betapapillomavirus with tropism for multiple anatomical niches.

Authors:  Danielle Bottalico; Zigui Chen; Boštjan J Kocjan; Katja Seme; Mario Poljak; Robert D Burk
Journal:  J Gen Virol       Date:  2012-05-02       Impact factor: 3.891

3.  p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes.

Authors:  Thibault Mesplède; David Gagnon; Fanny Bergeron-Labrecque; Ibrahim Azar; Hélène Sénéchal; François Coutlée; Jacques Archambault
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Myosin-X is essential to the intercellular spread of HIV-1 Nef through tunneling nanotubes.

Authors:  Jaime Uhl; Shivalee Gujarathi; Abdul A Waheed; Ana Gordon; Eric O Freed; Karine Gousset
Journal:  J Cell Commun Signal       Date:  2018-11-15       Impact factor: 5.782

5.  The presence of aberrant p53 pattern is a negative prognostic predictor in squamous cell carcinoma of the nasal vestibule.

Authors:  Domenic Vital; Gerhard F Huber; David Holzmann; Holger Moch; Kristian Ikenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-01       Impact factor: 2.503

Review 6.  Interplay between genetic and epigenetic factors governs common fragile site instability in cancer.

Authors:  Efrat Ozeri-Galai; Michal Tur-Sinai; Assaf C Bester; Batsheva Kerem
Journal:  Cell Mol Life Sci       Date:  2014-10-09       Impact factor: 9.261

7.  Role of human papillomavirus in the development of urothelial carcinoma.

Authors:  Dilek Yavuzer; Nimet Karadayi; Taflan Salepci; Huseyin Baloglu; Ahmet Bilici; Dilek Sakirahmet
Journal:  Med Oncol       Date:  2010-04-29       Impact factor: 3.064

Review 8.  Emerging human papillomavirus vaccines.

Authors:  Barbara Ma; Bharat Maraj; Nam Phuong Tran; Jayne Knoff; Alexander Chen; Ronald D Alvarez; Chien-Fu Hung; T-C Wu
Journal:  Expert Opin Emerg Drugs       Date:  2012-11-19       Impact factor: 4.191

9.  Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women.

Authors:  Agnihotram V Ramanakumar; Otelinda Goncalves; Harriet Richardson; Pierre Tellier; Alex Ferenczy; François Coutlée; Eduardo L Franco
Journal:  BMC Infect Dis       Date:  2010-11-11       Impact factor: 3.090

Review 10.  Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Chao-Qun Liu; Ying-Xiang Yang; Ping Lu; Shan-Feng Fu; Hui-Bin Qiu; Anthony E T Yeo
Journal:  J Biomed Biotechnol       Date:  2010-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.